查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599251

獸醫免疫診斷市場：按產品、動物、技術和最終用戶 - 全球預測 2025-2030

Veterinary Immunodiagnostics Market by Product (Analyzers, Consumables), Animal (Companion, Livestock), Technology, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸醫免疫診斷市場價值為35.8億美元，預計到2024年將達到39.1億美元，複合年成長率為9.59%，到2030年將達到68.1億美元。

動物免疫診斷市場包括檢測和測量動物特異性免疫反應的診斷測試和技術。該市場範圍從常規獸醫實踐到專業研究，為疾病診斷、疫苗評估以及動物健康和生物安全監測提供重要工具。寵物擁有量的迅速增加、牲畜健康管理需求以及通用感染疾病的出現推動了對獸醫免疫診斷的需求。應用範圍從血清學測試和酵素結合免疫吸附檢測法(ELISA) 到先進的分子診斷，以確保動物健康和生產力。最終用戶主要是獸醫醫院、研究實驗室和畜牧農民，他們都依賴這些診斷來進行快速、準確的評估，以幫助健康管理和研究。

主要市場統計
基準年[2023] 35.8億美元
預計年份 [2024] 39.1億美元
預測年份 [2030] 68.1億美元
複合年成長率（%） 9.59%

市場成長主要受到診斷準確性和效率方面技術進步以及對動物健康問題認知不斷提高的影響。此外，增加對先進診斷測試的監管支援正在推動市場需求。獸醫環境中對即時現場結果的需求為開發快速照護現場診斷解決方案提供了潛在的商機。為了利用這一點，建議投資攜帶式診斷設備以及與資料管理和疾病追蹤數位平台的整合。

然而，市場面臨一些限制，例如與先進診斷技術相關的高成本以及缺乏能夠執行和解釋複雜測試的熟練人員。此外，監管障礙可能會減緩新診斷方法向市場的推出。應對這些挑戰需要對成本降低策略和培訓計畫進行策略性投資，以提高技能水準。

有許多創新領域，包括允許同時測試多種疾病狀態的多重檢測的研究，以及能夠實現更具預測性的動物健康管理的基於人工智慧的診斷方法。總體而言，由於技術進步對創新和高效解決方案的需求不斷成長以及人們對預防性動物保健的興趣日益濃厚，獸醫免疫診斷市場顯示出巨大的潛力。

市場動態：快速發展的獸醫免疫診斷市場的關鍵市場洞察

供需的動態交互作用正在改變獸醫免疫診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病和通用感染疾病的盛行率增加
    • 政府動物保健舉措
    • 改善經濟國家的獸醫醫療設施
  • 市場限制因素
    • 免疫診斷測試成本上升
  • 市場機會
    • 動物免疫診斷藥物的研究進展
    • 單株抗體和重組抗原的潛力
  • 市場挑戰
    • 關於疫苗無效的問題

波特五力：開拓獸醫免疫診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更具彈性的市場地位。

PESTLE分析：了解外部對獸醫免疫診斷市場的影響

外部宏觀環境因素在塑造獸醫免疫診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物免疫診斷試劑市場競爭狀況

獸醫免疫診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸醫免疫診斷市場供應商的績效評估

FPNV定位矩陣是評估獸醫免疫診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪獸醫免疫診斷市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物免疫診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病和通用感染疾病的盛行率增加
      • 政府關於動物保健的舉措
      • 改善經濟中的獸醫護理設施
    • 抑制因素
      • 免疫診斷測試高成本
    • 機會
      • 動物免疫診斷藥物的研究進展
      • 單株抗體和重組抗原的潛力
    • 任務
      • 關於疫苗無效的問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章獸醫免疫診斷市場：依產品

  • 分析儀
  • 消耗品

第7章動物免疫診斷市場：依動物分類

  • 同胞
  • 家畜

第8章動物免疫診斷市場：依技術分類

  • 酵素連結免疫吸附試驗
  • 免疫檢測
  • 快速測試

第9章獸醫免疫診斷市場：依最終用戶分類

  • 醫院
  • 照護現場

第10章：北美和南美獸醫免疫診斷試劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太獸醫免疫診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東、非洲獸用免疫診斷試劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agrolabo SpA
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Neogen Corporation
  • Precision Biosensor Inc.
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.91 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 6.81 billion by 2030.

The veterinary immunodiagnostics market encompasses diagnostic tests and technologies that detect and measure specific immune responses in animals. This market's scope extends from routine veterinary practice to specialized research contexts, providing tools essential for disease diagnosis, vaccine evaluations, and monitoring animal health and biosecurity. The necessity for veterinary immunodiagnostics is driven by burgeoning pet ownership, livestock health management needs, and the emergence of zoonotic diseases. Applications range from serological tests and enzyme-linked immunosorbent assays (ELISAs) to advanced molecular diagnostics employed to ensure animal health and productivity. End-users predominantly include veterinary hospitals, research laboratories, and livestock farms, each relying on these diagnostics for quick, accurate assessments that inform health management or research studies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.58 billion
Estimated Year [2024] USD 3.91 billion
Forecast Year [2030] USD 6.81 billion
CAGR (%) 9.59%

Market growth is predominantly influenced by technological advancements in diagnostic accuracy and efficiency, alongside the growing awareness of animal health issues. Additionally, increasing regulatory support for advanced diagnostic testing fuels market demand. Potential opportunities await in the development of rapid, point-of-care diagnostic solutions, driven by the necessity for immediate and on-site results in veterinary settings. To capitalize on this, investments in portable diagnostics and integration with digital platforms for data management and disease tracking are recommended.

However, the market faces limitations such as high costs associated with advanced diagnostic technologies and a shortage of skilled personnel able to run and interpret complex tests. Furthermore, regulatory hurdles can delay the introduction of novel diagnostics in the market. Addressing these challenges requires strategic investments in cost-reduction strategies and training programs to enhance skill levels.

Innovation is fertile in areas like multiplex assays, which allow for the simultaneous testing of multiple conditions, and furthering research into AI-driven diagnostics for more predictive animal health management. Overall, the veterinary immunodiagnostics market shows robust potential, driven by a rising demand for innovative, efficient solutions underpinned by technological advancement and increasing focus on preventive animal healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Immunodiagnostics Market

The Veterinary Immunodiagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases and zoonotic diseases
    • Government initiatives for animal healthcare
    • Improving veterinary care facilities in economies
  • Market Restraints
    • High cost of immunodiagnostics tests
  • Market Opportunities
    • Advances in veterinary immunodiagnostics
    • Potential for monoclonal antibodies and recombinant antigens
  • Market Challenges
    • Issues relating to ineffectiveness of vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Immunodiagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Immunodiagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Immunodiagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Immunodiagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Immunodiagnostics Market

A detailed market share analysis in the Veterinary Immunodiagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Immunodiagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Immunodiagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Immunodiagnostics Market

A strategic analysis of the Veterinary Immunodiagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Immunodiagnostics Market, highlighting leading vendors and their innovative profiles. These include Agrolabo S.p.A., Biogal Galed Labs, BioMerieux S.A., BioNote, Inc., Fassisi GmbH, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, Neogen Corporation, Precision Biosensor Inc., Randox Laboratories, Ltd., Shenzhen Bioeasy Biotechnology Co., Ltd., Shenzhen Mindray Animal Medical Technology Co., Ltd., SKYER, Inc., Skyla Corporation, Thermo Fisher Scientific Inc., Vimian Group AB, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Immunodiagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzers and Consumables.
  • Based on Animal, market is studied across Companion and Livestock.
  • Based on Technology, market is studied across ELISA, Radioimmunoassay, and Rapid Tests.
  • Based on End User, market is studied across Hospital and Point-of-Care.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases and zoonotic diseases
      • 5.1.1.2. Government initiatives for animal healthcare
      • 5.1.1.3. Improving veterinary care facilities in economies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of immunodiagnostics tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in veterinary immunodiagnostics
      • 5.1.3.2. Potential for monoclonal antibodies and recombinant antigens
    • 5.1.4. Challenges
      • 5.1.4.1. Issues relating to ineffectiveness of vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Immunodiagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables

7. Veterinary Immunodiagnostics Market, by Animal

  • 7.1. Introduction
  • 7.2. Companion
  • 7.3. Livestock

8. Veterinary Immunodiagnostics Market, by Technology

  • 8.1. Introduction
  • 8.2. ELISA
  • 8.3. Radioimmunoassay
  • 8.4. Rapid Tests

9. Veterinary Immunodiagnostics Market, by End User

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Point-of-Care

10. Americas Veterinary Immunodiagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Immunodiagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Immunodiagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agrolabo S.p.A.
  • 2. Biogal Galed Labs
  • 3. BioMerieux S.A.
  • 4. BioNote, Inc.
  • 5. Fassisi GmbH
  • 6. FUJIFILM Holdings Corporation
  • 7. Heska Corporation
  • 8. IDEXX Laboratories, Inc.
  • 9. IDvet
  • 10. Neogen Corporation
  • 11. Precision Biosensor Inc.
  • 12. Randox Laboratories, Ltd.
  • 13. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 14. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 15. SKYER, Inc.
  • 16. Skyla Corporation
  • 17. Thermo Fisher Scientific Inc.
  • 18. Vimian Group AB
  • 19. Virbac S.A.
  • 20. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY IMMUNODIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY IMMUNODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY IMMUNODIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023